
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Anti-angiogenic Targets: Angiopoietin and Angiopoietin Receptors
Elina A. Kiss, Pipsa Saharinen
Springer eBooks (2019), pp. 227-250
Closed Access | Times Cited: 24
Elina A. Kiss, Pipsa Saharinen
Springer eBooks (2019), pp. 227-250
Closed Access | Times Cited: 24
Showing 24 citing articles:
Anti-Angiogenic Therapy: Current Challenges and Future Perspectives
Filipa Lopes‐Coelho, Filipa Martins, Sofia A. Pereira, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3765-3765
Open Access | Times Cited: 283
Filipa Lopes‐Coelho, Filipa Martins, Sofia A. Pereira, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3765-3765
Open Access | Times Cited: 283
Angiopoietin inhibitors: A review on targeting tumor angiogenesis
Parmar Digna, Madhavi Apte
European Journal of Pharmacology (2021) Vol. 899, pp. 174021-174021
Closed Access | Times Cited: 93
Parmar Digna, Madhavi Apte
European Journal of Pharmacology (2021) Vol. 899, pp. 174021-174021
Closed Access | Times Cited: 93
Interplay Between Extracellular Matrix Remodeling and Angiogenesis in Tumor Ecosystem
Rohit Siddhartha, Minal Garg
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 3, pp. 291-305
Open Access | Times Cited: 25
Rohit Siddhartha, Minal Garg
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 3, pp. 291-305
Open Access | Times Cited: 25
Natural products targeting tumour angiogenesis
Xiaohua Lu, Lara Johanna Friedrich, Thomas Efferth
British Journal of Pharmacology (2023)
Open Access | Times Cited: 23
Xiaohua Lu, Lara Johanna Friedrich, Thomas Efferth
British Journal of Pharmacology (2023)
Open Access | Times Cited: 23
Immunotherapies targeting tumor vasculature: challenges and opportunities
Hassan Dianat‐Moghadam, Reza Nedaeinia, Mohsen Keshavarz, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Hassan Dianat‐Moghadam, Reza Nedaeinia, Mohsen Keshavarz, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Neo-vascularization-based therapeutic perspectives in advanced ovarian cancer
Vipul Bhardwaj, Xi Zhang, Vijay Pandey, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188888-188888
Closed Access | Times Cited: 13
Vipul Bhardwaj, Xi Zhang, Vijay Pandey, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188888-188888
Closed Access | Times Cited: 13
Endothelial extracellular vesicles enhance vascular self-assembly in engineered human cardiac tissues
Karl T. Wagner, Rick Xing Ze Lu, Shira Landau, et al.
Biofabrication (2024) Vol. 16, Iss. 4, pp. 045037-045037
Closed Access | Times Cited: 4
Karl T. Wagner, Rick Xing Ze Lu, Shira Landau, et al.
Biofabrication (2024) Vol. 16, Iss. 4, pp. 045037-045037
Closed Access | Times Cited: 4
Endothelial cell in tumor angiogenesis: Origins, mechanisms, and therapeutic implication
Yulong Han, Binqiang Zhu, Shu Meng
Genes & Diseases (2025), pp. 101611-101611
Open Access
Yulong Han, Binqiang Zhu, Shu Meng
Genes & Diseases (2025), pp. 101611-101611
Open Access
Angioregulatory microRNAs in breast cancer: Molecular mechanistic basis and implications for therapeutic strategies
Mohammad Hasan Soheilifar, Nastaran Masoudi-Khoram, Soheil Madadi, et al.
Journal of Advanced Research (2021) Vol. 37, pp. 235-253
Open Access | Times Cited: 20
Mohammad Hasan Soheilifar, Nastaran Masoudi-Khoram, Soheil Madadi, et al.
Journal of Advanced Research (2021) Vol. 37, pp. 235-253
Open Access | Times Cited: 20
Chronic intermittent hypoxia elicits distinct transcriptomic responses among neurons and oligodendrocytes within the brainstem of mice.
Hemalatha Bhagavan, Aguan Wei, Luíz M. Oliveira, et al.
AJP Lung Cellular and Molecular Physiology (2024) Vol. 326, Iss. 6, pp. L698-L712
Closed Access | Times Cited: 2
Hemalatha Bhagavan, Aguan Wei, Luíz M. Oliveira, et al.
AJP Lung Cellular and Molecular Physiology (2024) Vol. 326, Iss. 6, pp. L698-L712
Closed Access | Times Cited: 2
Defining the Role of Oral Pathway Inhibitors as Targeted Therapeutics in Arteriovenous Malformation Care
Ann Mansur, Ivan Radovanovic
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1289-1289
Open Access | Times Cited: 2
Ann Mansur, Ivan Radovanovic
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1289-1289
Open Access | Times Cited: 2
Combined Treatment with Acalabrutinib and Rapamycin Inhibits Glioma Stem Cells and Promotes Vascular Normalization by Downregulating BTK/mTOR/VEGF Signaling
Yu-Kai Su, Oluwaseun Adebayo Bamodu, I‐Chang Su, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 876-876
Open Access | Times Cited: 16
Yu-Kai Su, Oluwaseun Adebayo Bamodu, I‐Chang Su, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 876-876
Open Access | Times Cited: 16
In Vivo Tumor-Suppressing and Anti-Angiogenic Activities of a Recombinant Anti-CD3ε Nanobody in Breast Cancer Mice Model
Azadeh Sharif Khatibi, Nasim Hayati Roodbari, Keivan Majidzade-A, et al.
Immunotherapy (2019) Vol. 11, Iss. 18, pp. 1555-1567
Closed Access | Times Cited: 14
Azadeh Sharif Khatibi, Nasim Hayati Roodbari, Keivan Majidzade-A, et al.
Immunotherapy (2019) Vol. 11, Iss. 18, pp. 1555-1567
Closed Access | Times Cited: 14
Incorporation of immunotherapies and nanomedicine to better normalize angiogenesis-based cancer treatment
Saade Abdalkareem Jasim, I.M. Farber, Sara Abdalrazzaq M. Noraldeen, et al.
Microvascular Research (2024) Vol. 154, pp. 104691-104691
Closed Access | Times Cited: 1
Saade Abdalkareem Jasim, I.M. Farber, Sara Abdalrazzaq M. Noraldeen, et al.
Microvascular Research (2024) Vol. 154, pp. 104691-104691
Closed Access | Times Cited: 1
Receptor-Based Strategies for Overcoming Resistance in Cancer Therapy
Naresh Sah, Abdul Althaf Shaik, Ganesh Acharya, et al.
Receptors (2024) Vol. 3, Iss. 4, pp. 425-443
Open Access | Times Cited: 1
Naresh Sah, Abdul Althaf Shaik, Ganesh Acharya, et al.
Receptors (2024) Vol. 3, Iss. 4, pp. 425-443
Open Access | Times Cited: 1
A comprehensive insight into the role of molecular pathways affected by the Angiopoietin and Tie system involved in hematological malignancies' pathogenesis
Ying Zhang, Shoufang Xu, Feiyu Jiang, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154677-154677
Closed Access | Times Cited: 3
Ying Zhang, Shoufang Xu, Feiyu Jiang, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154677-154677
Closed Access | Times Cited: 3
Transcriptome-Guided Drug Repurposing for Aggressive SCCs
Roland Zauner, Monika Wimmer, Sonja Dorfer, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 1007-1007
Open Access | Times Cited: 3
Roland Zauner, Monika Wimmer, Sonja Dorfer, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 1007-1007
Open Access | Times Cited: 3
Dysfunctional APPL1-Mediated Epigenetic Regulation in Diabetic Vascular Injury
Yunhui Du, Yanru Duan, Jianli Zhao, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 12
Closed Access | Times Cited: 1
Yunhui Du, Yanru Duan, Jianli Zhao, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 12
Closed Access | Times Cited: 1
Molecular mechanism of anticancer effect of heat shock protein 90 inhibitor BIIB021 in human bladder cancer cell line
Aydemir Asdemır, Aykut Özgür
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 7, pp. 5167-5177
Open Access
Aydemir Asdemır, Aykut Özgür
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 7, pp. 5167-5177
Open Access
Increased levels of Angiogenic Factors In Microvascular Angina
Elmira Roshani-Asl, Yousef Rasmi, Mohammad Hassan Khadem Ansari, et al.
Medicine and Pharmacy Reports (2018) Vol. 92, Iss. 1, pp. 31-35
Open Access | Times Cited: 1
Elmira Roshani-Asl, Yousef Rasmi, Mohammad Hassan Khadem Ansari, et al.
Medicine and Pharmacy Reports (2018) Vol. 92, Iss. 1, pp. 31-35
Open Access | Times Cited: 1
Combination therapy with Azithromycin, Pentoxifylline and Dexamethasone shows Complete Recovery in Severe COVID 19: Case Series of Patients in First and Second wave of Pandemic in India.
Rupinder Kler, Anirudh Mukherjee, Ms Pratiti Banerjee, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 1
Rupinder Kler, Anirudh Mukherjee, Ms Pratiti Banerjee, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 1
Chromatin accessibility shapes tumor architecture and microenvironment in clear cell renal cell carcinoma
Yige Wu, Nadezhda V. Terekhanova, Wagma Caravan, et al.
Research Square (Research Square) (2022)
Open Access
Yige Wu, Nadezhda V. Terekhanova, Wagma Caravan, et al.
Research Square (Research Square) (2022)
Open Access
Therapeutic Intervention of Glioma with the Novel Antineoplastic Agent T11TS: The Story so Far
Suhnrita Chaudhuri, Sagar Acharya, Swapna Chaudhuri
Immunotherapy (2022) Vol. 14, Iss. 15, pp. 1263-1277
Closed Access
Suhnrita Chaudhuri, Sagar Acharya, Swapna Chaudhuri
Immunotherapy (2022) Vol. 14, Iss. 15, pp. 1263-1277
Closed Access
Combination therapy with Azithromycin, Pentoxifylline and Dexamethasone shows Complete Recovery in Severe COVID 19: Case Series of Patients in First and Second wave of Pandemic in India.
Rupinder Kler, Dilip Vaishnav, Ms Pratiti Banerjee, et al.
Research Square (Research Square) (2021)
Open Access
Rupinder Kler, Dilip Vaishnav, Ms Pratiti Banerjee, et al.
Research Square (Research Square) (2021)
Open Access